22:44 , Jan 7, 2019 |  BC Extra  |  Politics & Policy

Bipartisan bill to streamline U.S. response to foreign theft of IP may hasten clarity on biotech impact

As the biopharma industry awaits guidance from the government on the scope and potential impact of proposed technology export controls, a new congressional bill could help speed the process. Members of the Senate Select Committee...
18:30 , Nov 30, 2018 |  BC Week In Review  |  Financial News

Inflazome to bring inflammasome inhibitors to clinic with €40M series B

Inflazome Ltd. (Dublin, Ireland) raised €40 million ($45.7 million) in a series B round on Nov. 19, giving it the funds to take several of its inflammasome inhibitors to the clinic next year, including a...
20:11 , Nov 26, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Adenocarcinoma; brain cancer; lung cancer; neuroendocrine tumors Cell culture studies identified a nicotonic acetylcholine receptor α7 (CHRNA7) antagonist that could help treat glioblastoma, lung adenocarcinoma and neuroblastoma. Chemical synthesis and cell-based testing of structural...
20:22 , Nov 19, 2018 |  BC Extra  |  Financial News

Inflazome to bring inflammasome inhibitors to clinic with €40M series B

Inflazome Ltd. (Dublin, Ireland) raised €40 million ($45.7 million) in a series B round Monday, giving it the funds to take several of its inflammasome inhibitors to the clinic next year, including a Parkinson's disease...
18:39 , Oct 18, 2018 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Seizures In silico , cell culture and mouse studies identified a GABRB2/GABRB3 positive allosteric modulator (PAM) that could help treat seizures. In silico screening of a small molecule library for structural similarity to a...
19:11 , Feb 21, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Melanoma Cell culture and mouse studies suggest activating or overexpressing NCR2 could help treat melanoma. In a human melanoma cell line, supernatant from NK cells activated by the NCR2 ligand PDGFDD decreased growth compared...
22:56 , Jan 26, 2018 |  BC Extra  |  Financial News

Ping An hires COO, CMO

Ping An Insurance Co. of China Ltd. (HKSE:2318; Shanghai:601318) hired Donald Lacey as managing director and COO and Marco Huesch as managing director and CMO of the Ping An Global Voyager Fund. Lacey was managing...
22:16 , Aug 4, 2017 |  BioCentury  |  Finance

Milestone's options

Milestone Pharmaceuticals Inc. turned positive Phase II data for etripamil into an upsized $55 million series C round, which will give the cardiovascular company leeway to expand its core program or in-license a second cardio...
22:01 , Aug 1, 2017 |  BC Extra  |  Financial News

Milestone raises $55M in series C

Milestone Pharmaceuticals Inc. (Montreal, Quebec) raised $55 million in a series C round led by Novo Holdings A/S (Hellerup, Denmark). New investors Forbion Capital Partners and Tekla Capital Management also participated, as did existing investors...
17:27 , Feb 7, 2017 |  BC Extra  |  Financial News

Prexton raises EUR 29M in series B round

Neurology company Prexton Therapeutics S.A. (Plan-les-Ouates, Switzerland) raised EUR 29 million ($31.2 million) in a series B round co-led by Forbion Capital Partners and Seroba Life Sciences. Also participating were prior investors MS Ventures, Ysios...